Last week, Abhijit Banerjee, Esther Duflo and Michael Kremer accepted the 2019 Nobel Memorial Prize in Economic Sciences. They were recognized for their use of randomized controlled trials, also known ...
The initiation of patient enrolment in the STARS DAPT trial marks an important milestone for Abluminus np. While contemporary ...
Section 1115 waivers in the Medicaid program are meant to be experiments for states to test coverage approaches that don't meet federal requirements. However, most of those evaluations fall far short, ...
MaaT Pharma Announces First Patient Randomized in IMMUNOLIFE Phase 2 Study Sponsored by Gustave Roussy, in Advanced NSCLC ...
Bivalirudin, a small-molecule direct thrombin inhibitor with a naturally reversible mechanism of action, has been investigated as a replacement for unfractionated heparin in patients with unstable ...
Editor’s note: This story was first published on Econofact. The Nobel Memorial prize in Economic Sciences awarded this year to Abhijit Banerjee, Esther Duflo, and Michael Kremer has focused attention ...
Although we support Lisbeth B. Schorr’s call for a variety of evaluation methods to identify promising social programs (“Innovative Reforms Require Innovative Scorekeeping,” Aug. 26, 2009.), we ...
A Randomized, Double-Blind, Placebo-Controlled, Phase III Study to Assess Efficacy and Safety of Weekly Farletuzumab in Combination With Carboplatin and Taxane in Patients With Ovarian Cancer in First ...
Randomized, evidence-based trials, long required for new drugs, are now underway for government policy initiatives. By Amy Finkelstein Facing an urgent need to determine whether new coronavirus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results